IMNN-001

N/A

Report date: 2025/05/21 11:12:26

Base Information

Drug NameIMNN-001
Drug Alias NameGEN-1 IL-12 DNA-based immunotherapyphIL-12-005/PPCGEN-1EGEN-001IMNN-001
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionInterleukin-12 stimulantsInterferon gamma stimulants
TargetsInterleukin-12Interferon gamma
Therapy Area/IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsColorectal Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesExpression Genetics
China Registration ClassN/A

Develop Information

Active CompaniesImunon IncHainan Poly Pharm Co Ltd
Inactive CompaniesEgen IncNational Cancer Institute
Active IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsPeritoneal Neoplasms +[4] 
Inactive IndicationsColorectal NeoplasmsCystadenocarcinoma, SerousCystadenocarcinoma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A